Antiproliferative and cytotoxic effects of some σ2 agonists and σ1 antagonists in tumour cell lines

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 370, Issue 2, 2004, Pages 106-113

  Colabufo, Nicola Antonio ^a   Berardi, Francesco ^a   Contino, Marialessandra ^a   Niso, Mauro ^a   Abate, Carmen ^a   Perrone, Roberto ^a   Tortorella, Vincenzo ^a  

^a Dipartimento Farmaco Chimico   (Italy)

Author keywords

1 Receptor antagonist; 2 Receptor agonist; (+) Pentazocine; AC927; NE100; PB28; Tumour cell lines

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; AC 297; AC 927; HALOPERIDOL; OPIATE AGONIST; PB 28; PENTAZOCINE; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENCY; EVALUATION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MODEL; TUMOR CELL;

ANIMALS; ANISOLES; ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; BRAIN; CELL LINE, TUMOR; GUANIDINES; GUINEA PIGS; HALOPERIDOL; HUMANS; LIGANDS; LIVER; MEMBRANES; PENTAZOCINE; PIPERAZINES; PROPYLAMINES; PYRIDINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, SIGMA;

EID: 4544295170     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0961-2     Document Type: Article

References (30)

1. Ablordeppey SY, Fischer JB, Burker Howie KJ, Glennon RA (1992) Design, synthesis and binding of sigma receptor ligands derived from butaclamol. Med Chem Res 2:368-375
2. 1A receptor ligands: ω-(tetralin-1-yl)-n-alkylamine derivatives. J Med Chem 39:176-182
3. 1 and EBP sites. Bioorg Med Chem 9:1325-1335
4. 2 activity. J Med Chem 47:2308-2317
5. Cavalieres V, Everaert H, Lahoutte T, Dierickx LO, John CS, Bossuyt A (2001) Labeled sigma receptor ligands: can their role in neurology and oncology be extended? Eur J Nucl Med Mol Imaging 28:133-135
6. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
7. 2 ligands in isolated guinea-pig bladder. Naunyn Schmiedeberg's Arch Pharmacol 138:106-112
8. Crawford KW, Bowen WD (2002) Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 62:313-322
9. 2 Receptors regulate changes in sphingolipid levels in breast tumor cells. Eur J Pharmacol 443:207-209
10. Crawford KW, Bittman R, Chun J, Byun HS, Bowen WD (2003) Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells. Cell Mol Biol 49:1017-1023
11. 18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor. Synapse 43:259-267
12. Itzak Y (1994) The sigma receptor (Neuroscience perspective series). Academic Press, London
13. John CS, Bowen WD, Saga T, Kimuya S, Vilner BJ, Baumgold J, Paik CH, Reba RC, Neuman RD, Varma VM, McAfee JG (1993) A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)-4-iodobenzamide. J Nucl Med 34:2169-2175
14. John CS, Vilner BJ, Schwartz AM, Bowen WD (1996) Characterization of sigma receptor binding sites in human biopsied solid breast tumor (abstract). J Nucl Med 37:267P
15. 125I]BP: a potential sigma receptor marker for human prostate tumors. Nucl Med Biol 25:189-194
16. Hellewell SB, Bowen WD (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527:244-253
17. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD (1994) Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 268:9-18
18. 18F-labeled 1-[2-(4-alkoxy-3-methoxyphemyl)ethyl]-4-(3-phenylpropyl) piperazines as sigma receptor ligands for positron emission tomography studies. Nucl Med Biol 30:273-284
19. Mach RH, Smith CR, al-Nabusi I, Whirrett BR, Childers SR, Wheeler KT (1997) Sigma-2 receptor as potential biomarkers of proliferation in breast cancer. Cancer Res 57:156-161
20. Maeda DY, Williams W, Bowen WD, Coop A (2000) A sigma-1 receptor selective analogue of BD1008. A potential substitute for (+)-opioids in sigma receptors binding assays. Bioorg Med Chem Lett 10:17-18
21. Matsumoto RR, Bowen WD, Tom MA, Van Nhi V, Truong DD, De Costa B (1995) Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280:301-310
22. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65:55-63
23. Nakazato A, Kumagai T, Otha K, Chaki S, Okuyama S, Tomisawa K (1999) Synthesis and SAR of 1-alkyl-2-phenylethylamine derivatives designed from N,N-dipropyl-4-methoxy-3-(2-phenylethoxy)phenylethylamine to discover sigma(1) ligands. J Med Chem 42:3965-3970
24. 2 receptor affinity. Med Chem Res 10:201-207
25. Quirion R, Bowen WD, Itzak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Taylor DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85-86
26. Tanaka M, Shirasaki T, Kaku S, Muramatsu M, Otomo S (1995) Characteristic of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig membranes. Naunyn Schmiedeberg's Arch Pharmacol 351:244-251
27. Vilner BJ, Bowen WD (2000) Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J Pharmacol Exp Ther 292:900-911
28. Vilner BJ, John CS, Bowen WD (1995a) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 55:408-413
29. Vilner BJ, de Costa BR, Bowen WD (1995b) Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability. J Neurosci 15:117-134
30. Walker JM, Bowen WD, Walker FO, Matsumoto RR, de Costa BR, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355-402